Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases
暂无分享,去创建一个
Malak Kotb | Nahla Ihendyane | Donald E. Low | Sonia Chatellier | A. Norrby-Teglund | M. Kotb | D. Low | S. Chatellier | F. Khambaty | Hesham Basma | Rita G. Kansal | Anna Norrby-Teglund | Allison McGeer | R. Kansal | Farukh Khambaty | H. Basma | A. McGeer | N. Ihendyane
[1] S. Holm,et al. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. , 1992, The Journal of infectious diseases.
[2] M. Upton,et al. Genetic heterogeneity of M type 3 group A streptococci causing severe infections in Tayside, Scotland , 1996, Journal of clinical microbiology.
[3] B. Schwartz,et al. The Reemergence of Severe Group A Streptococcal Disease: an Evolutionary Perspective , 1998 .
[4] U. Andersson,et al. Bacterial Toxin‐Induced Cytokine Production Studied at the Single‐Cell Level , 1992, Immunological reviews.
[5] J. Musser,et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. , 1997, JAMA.
[6] S. Holm,et al. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. , 1992, The Journal of infectious diseases.
[7] V. Fischetti,et al. Streptococcal M protein: molecular design and biological behavior , 1989, Clinical Microbiology Reviews.
[8] B. Schwartz,et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. , 1993, JAMA.
[9] R. Kaul,et al. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. , 1996, Journal of immunology.
[10] J. Musser,et al. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. , 1993, The Journal of clinical investigation.
[11] Dwight R. Johnson,et al. emm typing and validation of provisional M types for group A streptococci. , 1999, Emerging infectious diseases.
[12] P. Huovinen,et al. Typing of group A streptococci by random amplified polymorphic DNA analysis , 1994, Journal of Clinical Microbiology.
[13] J. Vuopio‐Varkila,et al. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. , 1997, The Journal of infectious diseases.
[14] D. Stevens. Invasive group A streptococcus infections. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] A. Norrby-Teglund,et al. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates , 1997, Infection and immunity.
[16] J. Andersson,et al. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. , 1999, The Journal of infectious diseases.
[17] T. Proft,et al. Identification and Characterization of Novel Superantigens from Streptococcus pyogenes , 1999, The Journal of experimental medicine.
[18] Martin Pr,et al. Streptococcal Serogroup: A Epidemic in Norway 1987–1988 , 1990 .
[19] Dwight R. Johnson,et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. , 1997, The Journal of infectious diseases.
[20] M. Kotb,et al. Bacterial pyrogenic exotoxins as superantigens , 1995, Clinical microbiology reviews.
[21] A. Norrby-Teglund,et al. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. , 1994, The Journal of infectious diseases.
[22] B. Schwartz,et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. , 1999, Infection and immunity.
[23] J. Musser,et al. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease , 1995, Infection and immunity.
[24] R. George,et al. Extensive genetic diversity among clinical isolates of Streptococcus pyogenes serotype M5. , 1998, Microbiology.
[25] L. Björck,et al. Protein SIC, a Novel Extracellular Protein of Streptococcus pyogenes Interfering with Complement Function (*) , 1996, The Journal of Biological Chemistry.
[26] A. Norrby-Teglund,et al. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF) , 1994, Infection and immunity.
[27] J. Musser,et al. Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Kaul,et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. , 1997, The American journal of medicine.
[29] L. Burman,et al. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. , 1991, The Journal of infectious diseases.
[30] D. Low,et al. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991 , 1992, Journal of clinical microbiology.
[31] N. Saunders,et al. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate , 1989 .
[32] D. Stevens,et al. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. , 1996, The Journal of infectious diseases.
[33] J. Musser,et al. Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein , 1997, Journal of clinical microbiology.
[34] R. George,et al. Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease , 1995, Journal of clinical microbiology.
[35] S. Ichiyama,et al. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] J. Musser,et al. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes , 1991, The Journal of experimental medicine.
[37] F. Khambaty,et al. International dissemination of epidemic Vibrio cholerae by cargo ship ballast and other nonpotable waters , 1994, Applied and environmental microbiology.